October 2026 has been a month of big cheques and hard lessons for startup founders. Investors wrote their largest cheques to companies with real revenue and real customers, while punishing hype without sales, according to a review of the month’s funding trends published in October. The pattern was consistent across the biggest deals of the month.
FAKTA
- AI agent company Manus raised more than $500 million, announced 8 October 2026.
- Quantum startup Oratomic raised $475 million at a roughly $5.4 billion valuation.
- SignSplit emerged from stealth with a $400 million seed commitment at a $1 billion valuation.
- Fintech company Ramp raised $1.85 billion at a $60 billion valuation, reporting more than $2 billion in annualised revenue and positive cash flow.
- Chip company Tenstorrent raised a $1.5 billion Series E in the week of 13 to 19 October.
- Intero Biosystems won TechCrunch Disrupt 2026, held 13 to 15 October in San Francisco, beating 199 finalists.
The figures, compiled from company announcements and reporting by Crunchbase News, TechCrunch, Reuters and others, show a market that has moved decisively towards proof. Ramp alone accounted for roughly 85 percent of the $2.167 billion raised by six United States startups on 16 October, and its scale — more than $2 billion in annualised revenue — was central to its valuation.

Where the money went
The mega-rounds — rounds of $100 million or more — all went to companies with revenue and customers behind them, not to demo-stage promise. The three patterns underneath the headlines were clear: investors favoured AI infrastructure, proven commercial scale, and startups that pair technology with real operational control. Oratomic, a quantum startup, tripled its valuation in a single quarter, while SignSplit’s $400 million seed paid humans for AI data — a business built on operational control of a scarce input.
The cautionary tale
The month also carried a warning. Character.AI, once valued in the billions, ended with a $20 million asset sale to Disney, according to the funding review. The contrast with Ramp and Modal — which crossed a $1 billion run rate and tripled its valuation in five months — is the month’s clearest lesson: the market is punishing hype without revenue.
What founders should take from October
For founders building something much smaller, the lessons are practical: prove commercial traction before expecting big cheques, own a useful layer instead of building a frontier model from scratch, expect geopolitics to shape who can invest, pair technology with real operational control, and keep unit economics honest. Non-dilutive funding also remains open: the United States National Science Foundation’s SBIR/STTR programme offers up to $1.55 million with no equity taken, with a deadline of 4 November, while UNICEF Femtech Ventures offers up to $100,000 plus mentorship, also closing 4 November.
Conclusion
October 2026 did not reward the loudest pitch. It rewarded the run rate, the customer list and the platform that other businesses depend on. Founders who can show those things will find capital; founders who cannot will find the market far less forgiving than it was.






























